Article abstract


Nature Cell Biology 9, 36 - 44 (2006)
Published online: 17 December 2006 | doi:10.1038/ncb1515

Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1

Miki Nishio1,2, Ken-ichi Watanabe1, Junko Sasaki1,3, Choji Taya4, Shunsuke Takasuga1, Ryota Iizuka1, Tamas Balla5, Masakazu Yamazaki6, Hiroshi Watanabe6, Reietsu Itoh1, Shoko Kuroda3, Yasuo Horie7, Irmgard Förster8, Tak W. Mak9, Hiromichi Yonekawa4, Josef M. Penninger10, Yasunori Kanaho6, Akira Suzuki3,11 & Takehiko Sasaki1,2,11


Proper neutrophil migration into inflammatory sites ensures host defense without tissue damage. Phosphoinositide 3-kinase (PI(3)K) and its lipid product phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) regulate cell migration, but the role of PtdIns(3,4,5)P3-degrading enzymes in this process is poorly understood. Here, we show that Src homology 2 (SH2) domain-containing inositol-5-phosphatase 1 (SHIP1), a PtdIns(3,4,5)P3 phosphatase, is a key regulator of neutrophil migration. Genetic inactivation of SHIP1 led to severe defects in neutrophil polarization and motility. In contrast, loss of the PtdIns(3,4,5)P3 phosphatase PTEN had no impact on neutrophil chemotaxis. To study PtdIns(3,4,5)P3 metabolism in living primary cells, we generated a novel transgenic mouse (AktPH–GFP Tg) expressing a bioprobe for PtdIns(3,4,5)P3. Time-lapse footage showed rapid, localized binding of AktPH–GFP to the leading edge membrane of chemotaxing ship1+/+AktPH–GFP Tg neutrophils, but only diffuse localization in ship1-/-AktPH–GFP Tg neutrophils. By directing where PtdIns(3,4,5)P3 accumulates, SHIP1 governs the formation of the leading edge and polarization required for chemotaxis.

Top
  1. Department of Pathology and Immunology, Akita University School of Medicine, 1-1-1 Hondo, Akita 010–8543, Japan.
  2. Precursory Research for Embryonic Science and Technology, Japan Science and Technology Agency, Kawaguchi, Saitama 332–0012, Japan.
  3. Department of Molecular Biology, Akita University School of Medicine, 1-1-1 Hondo, Akita 010–8543, Japan.
  4. Department of Laboratory Animal Science, the Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Tokyo 113–8613, Japan.
  5. Endocrinology and Reproduction Research Branch, NICHD, National Institutes of Health, Bethesda, MD 20892, USA.
  6. Department of Pharmacology, the Tokyo Metropolitan Institute of Medical Science, Bunkyo-ku, Tokyo 113–8613, Japan.
  7. Department of Gastroenterology, Akita University School of Medicine, 1-1-1 Hondo, Akita 010–8543, Japan.
  8. Institut für Umweltmedizinische Forschung, University of Düsseldorf, Auf'm Hennekamp 50, 40225 Düsseldorf, Germany.
  9. Campbell Family Institute for Breast Cancer Research, 620 University Ave., Suite 706, Toronto, Ontario, Canada M5G 2C1.
  10. Institute of Molecular and Biotechnology of the Austrian Academy of Sciences, Dr Bohr-Gasse 3, A-1030 Vienna, Austria.
  11. These authors contributed equally to this work.

Correspondence to: Takehiko Sasaki1,2,11 e-mail: tsasaki@med.akita-u.ac.jp



MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

PTEN gives neutrophils direction

Nature Immunology News and Views (01 Jul 2008)

Leading the way

Nature Cell Biology News and Views (01 Jul 2002)

See all 6 matches for News And Views

Extra navigation

Subscribe to Nature Cell Biology

Subscribe

Open Innovation Challenges

natureproducts